home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

75.25 +0.48 (+0.64%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

49 50 Next >

Top 4 Must-Have Healthcare Stocks for Long-Term Growth

July 11, 2024

Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand.

Via MarketBeat

3 Breakthrough Medical Device Stocks to Invest In Now ↗

July 08, 2024

Uncover the potential of leading medical device stocks boasting solid fundamentals and a promising future ahead.

Via InvestorPlace

Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years ↗

July 05, 2024

Via Benzinga

2 Top Growth Stocks to Buy With $1,000 ↗

July 04, 2024

These stocks have excellent track records of beating the market.

Via The Motley Fool

Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

June 27, 2024

From DexCom, Inc.

Via Business Wire

Why NASDAQ:DXCM Is a Standout High-Growth Stock in a Consolidation Phase. ↗

June 24, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

Here's How Much $1000 Invested In DexCom 5 Years Ago Would Be Worth Today ↗

June 17, 2024

Via Benzinga

Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034 ↗

June 25, 2024

These millionaire-maker stocks could turn a $50,000 investment into $1 million by 2034 if their growth trajectories remain intact.

Via InvestorPlace

Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey ↗

June 21, 2024

Learn why DexCom, TransDigm, and Datadog, three hyped stocks trading at rich valuations, may not be the best additions to your portfolio.

Via InvestorPlace

Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes

June 20, 2024

From DexCom, Inc.

Via Business Wire

The 3 Best Diabetes Stocks to Buy in June 2024 ↗

June 19, 2024

There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy.

Via InvestorPlace

Peering Into DexCom's Recent Short Interest ↗

June 11, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,800 Today ↗

June 03, 2024

Via Benzinga

In-Depth Examination Of 6 Analyst Recommendations For DexCom ↗

May 30, 2024

Via Benzinga

What's New In the Consumer Tech World Last Week? News That You Should Know (June 9-June 15, 2024) ↗

June 16, 2024

Via Benzinga

Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom ↗

June 10, 2024

The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.

Via Investor's Business Daily

Apple Watch Now Directly Syncs With Dexcom's G7 Glucose Monitor ↗

June 09, 2024

Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone.

Via Benzinga

Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

June 05, 2024

From DexCom, Inc.

Via Business Wire

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

May 30, 2024

Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

June 04, 2024

Via Benzinga

Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems

June 03, 2024

From Dexcom, Inc.

Via Business Wire

Bull Market Buys: 2 Growth Stocks to Own for the Long Haul ↗

June 03, 2024

Innovation is paying off for both of these medical device specialists.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 31, 2024

Via Benzinga

Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? ↗

May 30, 2024

Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.

Via The Motley Fool

The 3 Best MedTech Stocks to Buy Now: May 2024 ↗

May 29, 2024

Explore the best MedTech stocks to buy now that are driven by AI's potential to revolutionize healthcare efficiency.

Via InvestorPlace

Topics Artificial Intelligence

Dexcom Announces Upcoming Conference Presentation

May 29, 2024

From DexCom, Inc.

Via Business Wire

Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM

May 29, 2024

From Tandem Diabetes Care, Inc.

Via Business Wire

3 Growth Stocks the New ‘GPT-4o’ AI Bot Says Will Make You Rich ↗

May 27, 2024

These three under-the-radar growth stocks picked by the new GPT-4o AI bot could deliver massive gains if the AI model is right.

Via InvestorPlace

Topics Artificial Intelligence

Google Parent Alphabet Is Selling Shares of 2 Hypergrowth Stocks and Piling Into a Promising Artificial Intelligence (AI) Company ↗

May 23, 2024

Alphabet oversees more than $2.5 billion of invested assets. In the March quarter, it dumped shares of two of its largest holdings and nearly quadrupled its stake in a fast-growing artificial...

Via The Motley Fool

Topics Artificial Intelligence

3 Cheap 5G Stocks to Buy Now: May 2024 ↗

May 13, 2024

Investors may want to pay close attention to cheap 5G stocks to buy and hold today. In fact, here are three.

Via InvestorPlace

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com